Hearing Loss Trial, Recruiting NCT07272473 Sponsor: Abant Izzet Baysal University Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT07272473
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with Meniere's disease in one or both ears
  • You are between 18 and 60 years old
  • You have been experiencing fluctuating symptoms or ongoing balance problems for at least 3 months
  • You have sufficient mental clarity to take part in balance training exercises, as measured by a standard memory and thinking test (confirm with trial site)
  • You are willing to take part in the study and sign a consent form

Who may not be able to join:

  • Your dizziness or vertigo is caused by something other than Meniere's disease
  • You currently have another serious or active medical condition
  • You have a neurological, psychological, or cognitive condition that affects your thinking or functioning
  • You have had orthopaedic (bone or joint) surgery within the last 3 months
  • You are planning to have surgery during the period of the rehabilitation programme
  • You have instability in the bones of your neck or upper spine
  • You have recently had an acute injury to your neck
  • You have a condition where blood flow through the main artery supplying the back of the brain is reduced (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: omer pala, associate professor, Abant Izzet Baysal University

Phone: +905344527440

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abant Izzet Baysal University
Registry
ClinicalTrials.gov
Start date
20 September 2025
Est. completion
30 March 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Balance assessments

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov